Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Caregivers for people with dementia are more likely to report having at least one modifiable risk factor linked to developing dementia.

The FDA plans to approve selected high-priority drug application submissions in 1 to 2 months rather than 10 to 12.

Automated data review assists in identifying problematic opioid usage, outperforming manual methods in sensitivity and positive predictive value.

Platelet-rich plasma combined with fractional laser therapy was a safe and effective treatment option for adults with vitiligo.

Mortality rates associated with calciphylaxis are lower than previously observed, with rates of 28.88% at 1-year and 29.92% at 2-years.

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately ...

The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), ...

Research on the preferences of patients with AD, caregivers, and health care providers may be influenced by pharmaceutical company sponsorship.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.